ANALYSIS EFFICACY OF ABATACEPT TREATMENT IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS.

被引：0
|
作者：
Borisova, M. [1 ]
Lukina, G. [1 ,2 ]
Yakov, S. [1 ]
Luchikhina, E. [3 ]
Karateev, D. [3 ]
Novikov, A. [2 ]
Aleksandrova, E. [2 ]
Aronova, E. [1 ]
Glukhova, S. [1 ]
Nasonov, E. [4 ,5 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Lab Monitoring Safety Antirheumat Treatment, Moscow, Russia
[2] AS Loginov Moscow Clin Sci Ctr, Dept Rheumatol, Moscow, Russia
[3] Moscow Reg Res & Clin Inst MONIKI, Dept Rheumatol, Moscow, Russia
[4] VA Nasonova Res Inst Rheumatol, Sci Director, Moscow, Russia
[5] IM Sechenov First Moscow State Med Univ, Dept Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2406
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0349
引用
收藏
页码：1300 / 1300
页数：1
相关论文
共 50 条
  • [1] Real-World Effectiveness and Safety of Subcutaneous Abatacept in Biologic-Naive vs. Biologic-Experienced RA Patients: The Abatacept Best Care Study
    Haraoui, Boulos
    Pope, Janet
    Fortin, Isabelle
    Rampakakis, Emmanouil
    Sampalis, John
    Romeyer, Francoise
    Atallah, Joseph
    Bessette, Louis
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1054 - 1054
  • [2] Real-World Effectiveness and Safety of Subcutaneous Abatacept in Biologic-Naive Vs. Biologic-Experienced RA Patients: The Abatacept Best Care Study
    Haraoui, B.
    Pope, Janet E.
    Fortin, Isabelle
    Rampakakis, Emmanouil
    Sampalis, John S.
    Romeyer, Francoise
    Atallah, Joseph
    Bessette, Louis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Response and radiographic progression in biologic-naive and biologic-experienced patients with rheumatoid arthritis treated with sirukumab
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 23 - 24
  • [4] RESPONSE AND RADIOGRAPHIC PROGRESSION IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SIRUKUMAB
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 723 - 723
  • [5] Health care utilization and cost implications of biologic treatment patterns among biologic-naive and biologic-experienced patients with moderate to severe psoriasis
    Feidman, Steven
    Palmer, Jacqueline
    Wang, Xinyue
    Tian, Haijun
    Wei, Zhongyuan
    Djatche, Laurence
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB151 - AB151
  • [6] Predictors of Persistency with TNFi in Biologic-Experienced Versus Biologic-Naive Psa Patients Enrolled in the Corrona Registry
    Etzel, C. J.
    Stolshek, Bradley S.
    Rebello, Sabrina
    Collier, David
    Mutebi, Alex
    Wade, Sally W.
    Malley, Wendi
    Greenberg, J. D.
    Harrold, Leslie R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Extended induction in the True North open-label extension study: Ozanimod efficacy in biologic-naive and biologic-experienced patients
    Dignass, A.
    Sparrow, M.
    Regueiro, M.
    Colombel, J-F
    Jain, A.
    Canavan, J. B.
    Wu, H.
    Lawlor, G.
    Osterman, M. T.
    Vermeire, S.
    Rubin, D. T.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 120 - 121
  • [8] Real world use of ixekizumab is associated with reductions in concomitant medications among biologic-experienced or biologic-naive patients with psoriasis
    Wu, Jashin J.
    Zhu, Baojin
    Burge, Russel
    Goldblum, Orin
    Choong, Casey
    Edson-Heredia, Emily
    Amato, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB114 - AB114
  • [9] Starting-dose trends over time in biologic-naive and biologic-experienced psoriasis patients initiated on ustekinumab or adalimumab
    Guerin, Annie
    Sundaram, Murali
    Gauthier, Genevieve
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB253 - AB253
  • [10] Real-World Use of Secukinumab Among Biologic-NaiVe and Biologic-Experienced Patients with Ankylosing Spondylitis in the United States
    Oelke, Kurt R.
    Garg, Rahul
    Li, Yunfeng
    Liu, Xing
    Zhou, Huanxue
    Park, Yujin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345